Panel of experts: Professor Steve Wesselingh South Australia Health and Medical Research Institute, Adelaide (Australia) Dr Kendra Sweet Haematologist at the MOFFITT Cancer Center and Research Institute, Tampa (USA)

Program:
COVID-19 vaccines overview: (Steve Wesselingh)

• Overview of COVID-19 vaccines
• Vaccine safety
• Vaccine effectiveness
• Vaccine variants
• Vaccine persistence
• Vaccines and immunocompromised people
• Open questions

COVID-19 vaccines for patients with CML (Kendra Sweet)

• Experience with CML patients infected by COVID-19
• COVID-19 vaccines assessibility for patients with CML
• Experience with COVID-19 vaccines in patients with CML
• Recommendations for patients with CML related to COVID-19 vaccines
• Patients' perspectives on COVID-19 vaccines

Q&A Session